Trial reportClinical cardiology2026
The Effect of Age on Improvement in Health-Related Quality of Life After Percutaneous Coronary Intervention.
Trial report in Clinical cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Effect of Age on Improvement in Health-Related Quality of Life After Percutaneous Coronary Intervention.Clinical cardiology · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionPercutaneous coronary intervention (PCI) is the first-line therapy in patients scheduled for coronary revascularization, aiming to relieve symptoms of coronary artery disease (CAD) and improve health-related quality of life (HRQoL) and prognosis. Particularly, in older adults, symptom alleviation and HRQoL are emphasized. However, it is not known whether older patients benefit from PCI equally to their younger peers. We used disease-specific and generic instruments to evaluate the improvement in HRQoL after PCI, comparing changes in three age groups.
methodsAltogether 300 patients undergoing PCI were divided into three age groups: ≥ 75 years (n = 89), 66-74 years (n = 117), and ≤ 65 years (n = 94). HRQoL was measured using the disease-specific Seattle Angina Questionnaire (SAQ-7) and the generic 15D instrument at baseline, one, and 12 months.
resultsStatistically and clinically significant improvements in the SAQ-7 and 15D scores were observed after one- and 12-month follow-up in all age groups. There were no differences in the 12-month improvements in the SAQ-7 and 15D scores between the groups. The 15D score started to decline after 1 month, particularly in the oldest group. The decline was associated with age-related rather than CAD-related 15D dimensions.
conclusionsOur findings on comparable improvement in disease-specific and generic HRQoL after PCI in older and younger patients are encouraging, particularly considering that the aims of PCI in older adults are predominantly symptom alleviation and improvement of daily activities. In addition, to overcome age-related changes in HRQoL, a disease-specific instrument should be incorporated in the evaluation of PCI on HRQoL. CLINICAL
trial registration5101114.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.